Medicamen Bio is not listed on NSE
AnnouncementsMedicamen Biotech; Outcome of board meeting
AnnouncementsMedicamen Biotech: Board meeting on March 31, 2014
AnnouncementsMedicamen Biotech: Updates on outcome of EGM
AnnouncementsMedicamen Biotech: Outcome of EGM
AnnouncementsMedicamen Biotech: Updates on outcome of AGM
AnnouncementsMedicamen Biotech: Outcome of AGM
No recommendations so far.What's your call on Medicamen Bio today? Read Investor view
|Company Name||Last Price||%
|Dr Reddys Labs||2539.35||-1.48||2939.80||1904.15||43,196.60|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
Medicamen Bio is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 8.49 crore.The company has reported a standalone sales of Rs 12.02 crore and a Net Loss of Rs 0.43 crore for the quarter ended Dec 2013.
The company management includes B K Gupta - Managing Director, Jitendra Nath Ojha - Whole Time Director, Sanjay Bansal - Director, Ashutosh Gupta - Director, Rajinder Kr Gupta - Director, M L Parnami - Director, J N Ojha - Director, Harshita Sharma - Additional Director.
It is listed on the BSE with a BSE Code of 531146.
Its Registered office is at 10 Community Centre, No. 2 Ashok Vihar Phase-II, Delhi,Delhi - 110052.
Their Registrars are Link Intime India Pvt. Ltd.